Skip to main content
. 2019 Oct 7;20(6):5002–5020. doi: 10.3892/mmr.2019.10730

Figure 5.

Figure 5.

Validation of the ability of microRNA-132-3p to distinguish cholangiocarcinoma tissues from non-cancerous tissues. (A) sROC. (B) Pooled sensitivity and specificity. (C) Positive and negative likelihood ratios. (D) Negative likelihood ratios. (E) Forest plot of diagnostic odds ratio. sROC, summary receiver operating characteristic; RT-qPCR, reverse transcription-quantitative PCR; TCGA, The Cancer Genome Atlas.